Literature DB >> 26150888

Statins and their effect on cognition: Let's clear up the confusion.

Jérémie M Gauthier1, Anne Massicotte1.   

Abstract

Year:  2015        PMID： 26150888      PMCID： PMC4483758          DOI： 10.1177/1715163515578692

Source DB:  PubMed          Journal:  Can Pharm J (Ott)        ISSN： 1715-1635


× No keyword cloud information.
  11 in total

Review 1.  In-office mental status testing: a practical guide.

Authors:  D Mungas
Journal:  Geriatrics       Date:  1991-07

2.  Sensitivity of four psychometric tests to measure cognitive changes in brain aging-population-based studies.

Authors:  Cécile Proust-Lima; Hélène Amieva; Jean-François Dartigues; Hélène Jacqmin-Gadda
Journal:  Am J Epidemiol       Date:  2006-11-14       Impact factor: 4.897

Review 3.  Statins and cognitive function: a systematic review.

Authors:  Karl Richardson; Marisa Schoen; Benjamin French; Craig A Umscheid; Matthew D Mitchell; Steven E Arnold; Paul A Heidenreich; Daniel J Rader; Emil M deGoma
Journal:  Ann Intern Med       Date:  2013-11-19       Impact factor: 25.391

4.  Estimating the size of treatment effects: moving beyond p values.

Authors:  James J McGough; Stephen V Faraone
Journal:  Psychiatry (Edgmont)       Date:  2009-10

5.  An assessment by the Statin Cognitive Safety Task Force: 2014 update.

Authors:  Carlos H Rojas-Fernandez; Larry B Goldstein; Allan I Levey; Beth A Taylor; Vera Bittner
Journal:  J Clin Lipidol       Date:  2014 May-Jun       Impact factor: 4.766

Review 6.  Do statins impair cognition? A systematic review and meta-analysis of randomized controlled trials.

Authors:  Brian R Ott; Lori A Daiello; Issa J Dahabreh; Beth A Springate; Kimberly Bixby; Manjari Murali; Thomas A Trikalinos
Journal:  J Gen Intern Med       Date:  2015-01-10       Impact factor: 5.128

Review 7.  Therapeutic potential of statins in Alzheimer's disease.

Authors:  Nagaendran Kandiah; Howard H Feldman
Journal:  J Neurol Sci       Date:  2009-03-24       Impact factor: 3.181

8.  The Cochrane Collaboration's tool for assessing risk of bias in randomised trials.

Authors:  Julian P T Higgins; Douglas G Altman; Peter C Gøtzsche; Peter Jüni; David Moher; Andrew D Oxman; Jelena Savovic; Kenneth F Schulz; Laura Weeks; Jonathan A C Sterne
Journal:  BMJ       Date:  2011-10-18

9.  The clinical meaningfulness of ADAS-Cog changes in Alzheimer's disease patients treated with donepezil in an open-label trial.

Authors:  Kenneth Rockwood; Sherri Fay; Mary Gorman; Daniel Carver; Janice E Graham
Journal:  BMC Neurol       Date:  2007-08-30       Impact factor: 2.474

Review 10.  Unintended effects of statins from observational studies in the general population: systematic review and meta-analysis.

Authors:  Ana Filipa Macedo; Fiona Claire Taylor; Juan P Casas; Alma Adler; David Prieto-Merino; Shah Ebrahim
Journal:  BMC Med       Date:  2014-03-22       Impact factor: 8.775
View more
  7 in total

1.  Pharmacy students are vital to the future of the profession / Les étudiants en pharmacie moteur du changement.

Authors:  Ross T Tsuyuki
Journal:  Can Pharm J (Ott)       Date:  2015-05

Review 2.  Metabolic, inflammatory, and microvascular determinants of white matter disease and cognitive decline.

Authors:  Maggie Wang; Jennifer E Norman; Vivek J Srinivasan; John C Rutledge
Journal:  Am J Neurodegener Dis       Date:  2016-11-30

3.  Effects of blood pressure and lipid lowering on cognition: Results from the HOPE-3 study.

Authors:  Jackie Bosch; Martin O'Donnell; Balakumar Swaminathan; Eva Marie Lonn; Mikul Sharma; Gilles Dagenais; Rafael Diaz; Kamlesh Khunti; Basil S Lewis; Alvaro Avezum; Claes Held; Matyas Keltai; Christopher Reid; William D Toff; Antonio Dans; Lawrence A Leiter; Karen Sliwa; Shun Fu Lee; Janice M Pogue; Robert Hart; Salim Yusuf
Journal:  Neurology       Date:  2019-02-27       Impact factor: 9.910

Review 4.  Anti-PCSK9 antibodies for hypercholesterolaemia: Overview of clinical data and implications for primary care.

Authors:  Olivier S Descamps; Uwe Fraass; Ricardo Dent; Winfried März; Ioanna Gouni-Berthold
Journal:  Int J Clin Pract       Date:  2017-07-27       Impact factor: 2.503

Review 5.  Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) in the Brain and Relevance for Neuropsychiatric Disorders.

Authors:  Emma M O'Connell; Falk W Lohoff
Journal:  Front Neurosci       Date:  2020-06-12       Impact factor: 4.677

6.  Associations of subclinical cerebral small vessel disease and processing speed in non-demented subjects: A 7-year study.

Authors:  Isabel Hotz; Pascal Frédéric Deschwanden; Susan Mérillat; Franziskus Liem; Spyridon Kollias; Lutz Jäncke
Journal:  Neuroimage Clin       Date:  2021-11-23       Impact factor: 4.881

Review 7.  Statin-Related Myotoxicity: A Comprehensive Review of Pharmacokinetic, Pharmacogenomic and Muscle Components.

Authors:  Richard Myles Turner; Munir Pirmohamed
Journal:  J Clin Med       Date:  2019-12-20       Impact factor: 4.241
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.